# ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis

> **NCT02909556** · NA · COMPLETED · sponsor: **Symetis SA** · enrollment: 120 (actual)

## Conditions studied

- Aortic Stenosis

## Interventions

- **DEVICE:** Transcatheter aortic valve replacement

## Key facts

- **NCT ID:** NCT02909556
- **Lead sponsor:** Symetis SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-16
- **Primary completion:** 2018-01-24
- **Final completion:** 2023-01-13
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02909556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02909556, "ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02909556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*